Apigenin-Loaded Stealth Liposomes: Development and Pharmacokinetic Studies for Enhanced Plasma Retention of Drug in Cancer Therapy

[1]  M. M. Ahmed,et al.  Preparation and Optimization of Naringin Oral Nanocarrier: In Vitro Characterization and Antibacterial Activity , 2022, Coatings.

[2]  S. Jalalpure,et al.  Optimization of a Validated UV-Spectrophotometric Methodology for Assessment of Apigenin in Bulk Powder , 2022, Indian Journal of Pharmaceutical Education and Research.

[3]  Cristóbal N. Aguilar,et al.  A review on antibacterial and therapeutic plasma-enhanced activities of natural extracts , 2021 .

[4]  S. Jalalpure,et al.  A single robust stability-indicating RP-HPLC analytical tool for apigenin quantification in bulk powder and in nanoliposomes: a novel approach , 2021, Future Journal of Pharmaceutical Sciences.

[5]  Sabu Thomas,et al.  A critical review on multifunctional smart materials ‘nanographene’ emerging avenue: nano-imaging and biosensor applications , 2021, Critical Reviews in Solid State and Materials Sciences.

[6]  J. Kristl,et al.  Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy , 2021, Antioxidants.

[7]  O. Sammour,et al.  Ethanol injection technique for liposomes formulation: An insight into development, influencing factors, challenges and applications , 2020 .

[8]  F. Shakeel,et al.  Enhancing Oral Bioavailability of Apigenin Using a Bioactive Self-Nanoemulsifying Drug Delivery System (Bio-SNEDDS): In Vitro, In Vivo and Stability Evaluations , 2020, Pharmaceutics.

[9]  M. Hsieh,et al.  Recent Advances in Theranostic Polymeric Nanoparticles for Cancer Treatment: A Review. , 2020, International journal of pharmaceutics.

[10]  G. Sethi,et al.  Piceatannol: A Natural Stilbene for the Prevention and Treatment of Cancer. , 2020, Pharmacological research.

[11]  B. Salehi,et al.  The Therapeutic Potential of Apigenin , 2019, International journal of molecular sciences.

[12]  A. Alshetaili,et al.  Dissolution and bioavailability improvement of bioactive apigenin using solid dispersions prepared by different techniques , 2018, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[13]  Vivek Dave,et al.  Formulation and characterization of an apigenin‐phospholipid phytosome (APLC) for improved solubility, in vivo bioavailability, and antioxidant potential , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[14]  Fanling Meng,et al.  Recent progress on nanoparticle-based drug delivery systems for cancer therapy , 2017, Cancer biology & medicine.

[15]  Wei Cheng,et al.  Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells. , 2017, Oncology reports.

[16]  M. Mandal,et al.  Enhanced chemotherapeutic efficacy of apigenin liposomes in colorectal cancer based on flavone-membrane interactions. , 2017, Journal of colloid and interface science.

[17]  Darin A Mohamed,et al.  Apigenin potentiates the antitumor activity of 5‐FU on solid Ehrlich carcinoma: Crosstalk between apoptotic and JNK‐mediated autophagic cell death platforms , 2017, Toxicology and applied pharmacology.

[18]  K. Neville,et al.  Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy , 2017, Journal of Hematology & Oncology.

[19]  Li Wang,et al.  Preparation, characterization and antitumor activity evaluation of apigenin nanoparticles by the liquid antisolvent precipitation technique , 2017, Drug delivery.

[20]  Hsiu-Chen Huang,et al.  Chrysin, Abundant in Morinda citrifolia Fruit Water-EtOAc Extracts, Combined with Apigenin Synergistically Induced Apoptosis and Inhibited Migration in Human Breast and Liver Cancer Cells. , 2016, Journal of agricultural and food chemistry.

[21]  Xiaojue Zhu,et al.  Apigenin suppresses colorectal cancer cell proliferation, migration and invasion via inhibition of the Wnt/β-catenin signaling pathway. , 2016, Oncology letters.

[22]  Kwang-Ho Lee,et al.  Inhibition of glutamine utilization sensitizes lung cancer cells to apigenin-induced apoptosis resulting from metabolic and oxidative stress. , 2016, International journal of oncology.

[23]  N. Sang,et al.  Uniform Nanosecond Pulsed Dielectric Barrier Discharge Plasma Enhances Anti‐Tumor Effects by Induction of Immunogenic Cell Death in Tumors and Stimulation of Macrophages , 2015 .

[24]  J. Woo,et al.  Apigenin induces caspase-dependent apoptosis by inhibiting signal transducer and activator of transcription 3 signaling in HER2-overexpressing SKBR3 breast cancer cells. , 2015, Molecular medicine reports.

[25]  B. Sudhakar,et al.  Factorial Design Studies and Biopharmaceutical Evaluation of Simvastatin Loaded Solid Lipid Nanoparticles for Improving the Oral Bioavailability , 2014 .

[26]  Yongtai Zhang,et al.  Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. , 2014, International journal of pharmaceutics.

[27]  Yaping Li,et al.  Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking. , 2013, Small.

[28]  U. Krishnan,et al.  Investigation on the stability of saquinavir loaded liposomes: implication on stealth, release characteristics and cytotoxicity. , 2012, International journal of pharmaceutics.

[29]  S. M. Afzal,et al.  Brain delivery of transferrin coupled indinavir submicron lipid emulsions--pharmacokinetics and tissue distribution. , 2011, Colloids and surfaces. B, Biointerfaces.

[30]  A. Pawar,et al.  Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine , 2010, Drug development and industrial pharmacy.

[31]  S. Garg,et al.  Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs. , 2010, Advanced drug delivery reviews.

[32]  Y. Pei,et al.  Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[33]  R. Lledo-Garcia,et al.  Bioavailability and pharmacokinetic model for ritonavir in the rat. , 2007, Journal of pharmaceutical sciences.

[34]  Y. Tsai,et al.  Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. , 2005, International journal of pharmaceutics.

[35]  H. Mukhtar,et al.  Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells , 2002, Oncogene.